Set-in-stone criteria will reduce risk for new biotech fund
Several boxes must be ticked off before new Danish-Swedish biotech fund Sound Bioventures is ready to invest. A high-energy team, the right development stage and an indication on the smaller side are all on the list, but medtech and diagnostic firms have been excluded, says founding partner Casper Breum.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
For many years, promising Danish life science firms and imaginative biotech entrepreneurs only had a few funds to turn to when raising capital to secure their futures: Lundbeckfonden, the Novo Nordisk Foundation and Sunstone Life Science Ventures.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
